ArticleThe journal of pathology. Clinical research2025

Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis.

Dominik Nann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.